Literature DB >> 29682622

Risk of hepatocellular carcinoma for patients treated with direct-acting antivirals: steps after hepatitis C virus eradication to achieve elimination.

Mei-Hsuan Lee1.   

Abstract

Entities:  

Year:  2018        PMID： 29682622      PMCID： PMC5897667          DOI： 10.21037/tgh.2018.02.03

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  19 in total

1.  Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.

Authors:  Sujan Ravi; Page Axley; DeAnn Jones; Sudha Kodali; Heather Simpson; Brendan M McGuire; Ashwani K Singal
Journal:  Gastroenterology       Date:  2017-02-02       Impact factor: 22.682

Review 2.  Toward the elimination of hepatitis C in the United States.

Authors:  Sammy Saab; Long Le; Satvir Saggi; Vinay Sundaram; Myron J Tong
Journal:  Hepatology       Date:  2018-06       Impact factor: 17.425

3.  Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.

Authors:  Hamish A Innes; Scott A McDonald; John F Dillon; Sam Allen; Peter C Hayes; David Goldberg; Peter R Mills; Stephen T Barclay; David Wilks; Heather Valerio; Ray Fox; Diptendu Bhattacharyya; Nicholas Kennedy; Judith Morris; Andrew Fraser; Adrian J Stanley; Peter Bramley; Sharon J Hutchinson
Journal:  Hepatology       Date:  2015-03-25       Impact factor: 17.425

4.  Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.

Authors:  Fasiha Kanwal; Jennifer Kramer; Steven M Asch; Maneerat Chayanupatkul; Yumei Cao; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2017-06-19       Impact factor: 22.682

Review 5.  Prevalence and treatment of chronic hepatitis C virus infection in the US Department of Veterans Affairs.

Authors:  Lauren A Beste; George N Ioannou
Journal:  Epidemiol Rev       Date:  2015-01-19       Impact factor: 6.222

6.  Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.

Authors:  Hashem B El-Serag; Fasiha Kanwal; Peter Richardson; Jennifer Kramer
Journal:  Hepatology       Date:  2016-04-19       Impact factor: 17.425

7.  Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

Authors:  Adriaan J van der Meer; Bart J Veldt; Jordan J Feld; Heiner Wedemeyer; Jean-François Dufour; Frank Lammert; Andres Duarte-Rojo; E Jenny Heathcote; Michael P Manns; Lorenz Kuske; Stefan Zeuzem; W Peter Hofmann; Robert J de Knegt; Bettina E Hansen; Harry L A Janssen
Journal:  JAMA       Date:  2012-12-26       Impact factor: 56.272

8.  Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia.

Authors:  Z M Younossi; H L Y Chan; Y Y Dan; M H Lee; Y-S Lim; E Kruger; S C Tan
Journal:  J Viral Hepat       Date:  2017-11-29       Impact factor: 3.728

9.  Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients.

Authors:  Kazumi Yamasaki; Masakuni Tateyama; Seigo Abiru; Atsumasa Komori; Shinya Nagaoka; Akira Saeki; Satoru Hashimoto; Ryu Sasaki; Shigemune Bekki; Yuki Kugiyama; Yuri Miyazoe; Atsushi Kuno; Masaaki Korenaga; Akira Togayachi; Makoto Ocho; Masashi Mizokami; Hisashi Narimatsu; Hiroshi Yatsuhashi
Journal:  Hepatology       Date:  2014-10-02       Impact factor: 17.425

10.  Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.

Authors:  Mei-Hsuan Lee; Chung-Feng Huang; Hsueh-Chou Lai; Chun-Yen Lin; Chia-Yen Dai; Chun-Jen Liu; Jing-Houng Wang; Jee-Fu Huang; Wen-Pang Su; Hung-Chih Yang; Kwong-Ming Kee; Ming-Lun Yeh; Po-Heng Chuang; Shih-Jer Hsu; Ching-I Huang; Jung-Ta Kao; Chieh-Chang Chen; Sheng-Hung Chen; Wen-Juei Jeng; Hwai-I Yang; Yong Yuan; Sheng-Nan Lu; I-Shyan Sheen; Chen-Hua Liu; Cheng-Yuan Peng; Jia-Horng Kao; Ming-Lung Yu; Wan-Long Chuang; Chien-Jen Chen
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.